135 related articles for article (PubMed ID: 34278900)
1. Body Mass Index Alters the Predictive Value of the Neutrophil-to-Lymphocyte Ratio and Systemic Inflammation Response Index in Laryngeal Squamous Cell Carcinoma Patients.
Murad LD; Silva TQ; Schilithz AOC; Monteiro MC; Murad LB; Fialho E
Nutr Cancer; 2022; 74(4):1261-1269. PubMed ID: 34278900
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Capacity of Systemic Inflammation Response Index, Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients with Hypopharyngeal Squamous Cell Carcinoma.
Wang T; Lin H; Hsueh C; Lau HC; Zhou J; Gong H; Tao L; Zhou L; Wu C
ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):453-463. PubMed ID: 35709701
[TBL] [Abstract][Full Text] [Related]
3. Low body mass index is associated with reduced intratumoral CD4
Murad LD; Silva TQ; Schilithz AOC; Fernandes PV; Monteiro M; Murad LB; Fialho E
Nutr Res; 2022 Jun; 102():1-12. PubMed ID: 35366454
[TBL] [Abstract][Full Text] [Related]
4. The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma.
Wang T; Zhang D; Tang D; Heng Y; Lu LM; Tao L
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5627-5636. PubMed ID: 36520215
[TBL] [Abstract][Full Text] [Related]
5. The systemic inflammation response index predicts the survival of patients with clinical T1-2N0 oral squamous cell carcinoma.
Song F; Cai H; Liao Y; Huang S; Jiang Y; Liang J; Xie N; Hou J
Oral Dis; 2022 Apr; 28(3):600-610. PubMed ID: 33486833
[TBL] [Abstract][Full Text] [Related]
6. Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.
Chen L; Zeng H; Yang J; Lu Y; Zhang D; Wang J; Kuang C; Zhu S; Wang M; Ma X
BMC Cancer; 2018 Aug; 18(1):816. PubMed ID: 30103707
[TBL] [Abstract][Full Text] [Related]
7. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis.
Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P
Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922
[TBL] [Abstract][Full Text] [Related]
8. Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma.
Valero C; Pardo L; Sansa A; Garcia Lorenzo J; López M; Quer M; León X
Head Neck; 2020 Feb; 42(2):336-343. PubMed ID: 31750591
[TBL] [Abstract][Full Text] [Related]
9. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
[No Abstract] [Full Text] [Related]
10. Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer.
Valero C; Zanoni DK; McGill MR; Ganly I; Morris LGT; Quer M; Shah JP; Wong RJ; León X; Patel SG
Cancer; 2020 Mar; 126(5):994-1003. PubMed ID: 31809562
[TBL] [Abstract][Full Text] [Related]
11. Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma.
Zubair F; McMahon J; Kryklyas G; Wicks C
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):589-595. PubMed ID: 35248409
[TBL] [Abstract][Full Text] [Related]
12. Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma.
Brkic FF; Kadletz L; Jank B; Mayer C; Heiduschka G; Brunner M
J Craniomaxillofac Surg; 2020 Jan; 48(1):33-37. PubMed ID: 31810849
[TBL] [Abstract][Full Text] [Related]
13. Utility of palliative prognostic index and neutrophil-to-lymphocyte ratio in predicting prognosis of end-stage squamous cell carcinoma of head and neck.
Higashino M; Sugimoto K; Onishi S; Okabe K; Yasuda C; Tadokoro H; Kawata R
Head Neck; 2024 Jan; 46(1):23-28. PubMed ID: 37850401
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Impacts of Pretreatment Peripheral Blood Ratio on Lymphocytes, Monocytes, and Neutrophils Among Patients with Laryngeal/Hypopharyngeal Cancer Treated by Chemoradiation/Radiation.
Chuang HC; Tsai MH; Lin YT; Chou MH; Huang TL; Chiu TJ; Lu H; Fang FM; Chien CY
Cancer Manag Res; 2020; 12():9013-9021. PubMed ID: 33061596
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study.
Yanni A; Buset T; Bouland C; Loeb I; Lechien JR; Rodriguez A; Journe F; Saussez S; Dequanter D
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4103-4111. PubMed ID: 35099595
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic score based on systemic inflammatory biomarkers for patients with oral squamous cell carcinoma.
Zhuang Z; Li Y; Hong Y; Chen L; Qian J; Lin J; Chen Q; Qiu Y; Lin L; Shi B; Pan L; Zheng X; Wang J; Liu F; He B; Chen F
Oral Dis; 2022 Apr; 28(3):631-638. PubMed ID: 33426698
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in patients with laryngeal squamous cell carcinoma.
Li Z; Qu Y; Yang Y; An W; Li S; Wang B; He Y; Li J; Shao Q; Qin L
Clin Otolaryngol; 2021 Mar; 46(2):395-405. PubMed ID: 33321001
[TBL] [Abstract][Full Text] [Related]
19. Nutritional status and inflammatory markers as survival predictors in pediatric central nervous system tumors.
Dos Santos ICL; da Silva Vargas Silva G; Murad LB; Murad LD
Clin Nutr ESPEN; 2023 Oct; 57():89-95. PubMed ID: 37739738
[TBL] [Abstract][Full Text] [Related]
20. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
[Next] [New Search]